Published in PLoS One on November 05, 2014
Visualization of cortical, subcortical and deep brain neural circuit dynamics during naturalistic mammalian behavior with head-mounted microscopes and chronically implanted lenses. Nat Protoc (2016) 0.85
Implications of gamma band activity in the pedunculopontine nucleus. J Neural Transm (Vienna) (2015) 0.80
Pharmacological profiling of zebrafish behavior using chemical and genetic classification of sleep-wake modifiers. Front Pharmacol (2015) 0.78
Direct Imaging of Hippocampal Epileptiform Calcium Motifs Following Kainic Acid Administration in Freely Behaving Mice. Front Neurosci (2016) 0.75
Multi-layer Cortical Ca2+ Imaging in Freely Moving Mice with Prism Probes and Miniaturized Fluorescence Microscopy. J Vis Exp (2017) 0.75
Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature (2013) 12.01
Coordinated memory replay in the visual cortex and hippocampus during sleep. Nat Neurosci (2006) 7.49
The human hippocampus and spatial and episodic memory. Neuron (2002) 6.09
GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience (2000) 5.81
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci (2000) 5.53
Hippocampus: cognitive processes and neural representations that underlie declarative memory. Neuron (2004) 5.15
Whole-brain functional imaging at cellular resolution using light-sheet microscopy. Nat Methods (2013) 5.09
Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem (2002) 4.45
Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature (1999) 4.36
The contributions of position, direction, and velocity to single unit activity in the hippocampus of freely-moving rats. Exp Brain Res (1983) 4.14
Functional differentiation in the hippocampus. Hippocampus (1998) 3.92
Integration and segregation of activity in entorhinal-hippocampal subregions by neocortical slow oscillations. Neuron (2006) 3.84
Automated analysis of cellular signals from large-scale calcium imaging data. Neuron (2009) 3.51
Long-term dynamics of CA1 hippocampal place codes. Nat Neurosci (2013) 3.06
Control of sleep and wakefulness. Physiol Rev (2012) 3.06
Nanotools for neuroscience and brain activity mapping. ACS Nano (2013) 2.74
Miniaturized integration of a fluorescence microscope. Nat Methods (2011) 2.63
GABA uptake regulates cortical excitability via cell type-specific tonic inhibition. Nat Neurosci (2003) 2.55
The slow (<1 Hz) rhythm of non-REM sleep: a dialogue between three cardinal oscillators. Nat Neurosci (2009) 2.51
Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease. Neuron (2012) 2.40
A model for memory systems based on processing modes rather than consciousness. Nat Rev Neurosci (2010) 2.32
GABA(A) receptor subunits in the rat hippocampus I: immunocytochemical distribution of 13 subunits. Neuroscience (1997) 2.27
Understanding memory through hippocampal remapping. Trends Neurosci (2008) 2.04
Quantitative localisation of synaptic and extrasynaptic GABAA receptor subunits on hippocampal pyramidal cells by freeze-fracture replica immunolabelling. Eur J Neurosci (2010) 2.03
Time-lapse imaging of disease progression in deep brain areas using fluorescence microendoscopy. Nat Med (2011) 1.99
Tonically activated GABAA receptors in hippocampal neurons are high-affinity, low-conductance sensors for extracellular GABA. Mol Pharmacol (2003) 1.65
Effect of zolpidem on miniature IPSCs and occupancy of postsynaptic GABAA receptors in central synapses. J Neurosci (1999) 1.65
Spatial selectivity of rat hippocampal neurons: dependence on preparedness for movement. Science (1989) 1.61
How vision and movement combine in the hippocampal place code. Proc Natl Acad Sci U S A (2012) 1.54
Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol (2000) 1.47
Altered pharmacology of synaptic and extrasynaptic GABAA receptors on CA1 hippocampal neurons is consistent with subunit changes in a model of alcohol withdrawal and dependence. J Pharmacol Exp Ther (2004) 1.46
Genetically encoded optical indicators for the analysis of neuronal circuits. Nat Rev Neurosci (2012) 1.46
Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs (2004) 1.44
Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. J Pharmacol Exp Ther (2009) 1.40
Distinct mechanisms regulate GABAA receptor and gephyrin clustering at perisomatic and axo-axonic synapses on CA1 pyramidal cells. J Physiol (2011) 1.25
Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone. Clin Pharmacokinet (2004) 1.25
The critical role of sleep spindles in hippocampal-dependent memory: a pharmacology study. J Neurosci (2013) 1.21
Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther (1986) 1.19
Patterns of mRNA and protein expression for 12 GABAA receptor subunits in the mouse brain. Neuroscience (2013) 1.17
Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther (1990) 1.17
Sleep for preserving and transforming episodic memory. Annu Rev Neurosci (2013) 1.15
Zolpidem for insomnia. Expert Opin Pharmacother (2012) 1.14
Prolongation of hippocampal miniature inhibitory postsynaptic currents in mice lacking the GABA(A) receptor alpha1 subunit. J Neurophysiol (2002) 1.14
The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. CNS Drugs (2004) 1.13
Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem. J Sleep Res (2009) 1.13
Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial. Am J Phys Med Rehabil (2009) 1.11
Engineering approaches to illuminating brain structure and dynamics. Neuron (2013) 1.11
Sleep and the single neuron: the role of global slow oscillations in individual cell rest. Nat Rev Neurosci (2013) 1.11
The role of serendipity in drug discovery. Dialogues Clin Neurosci (2006) 1.11
Anxiety, cognition, and habit: a multiple memory systems perspective. Brain Res (2009) 1.11
GABAA receptor subtype specific enhancement of inhibition in human motor cortex. J Physiol (2006) 1.10
Electrophysiological correlates of sleep homeostasis in freely behaving rats. Prog Brain Res (2011) 1.09
A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening. Br J Clin Pharmacol (1999) 1.09
Mechanisms of sleep induction by GABA(A) receptor agonists. J Clin Psychiatry (2007) 1.08
Gain control in CA1 pyramidal cells using changes in somatic conductance. J Neurosci (2010) 1.07
GABA A/Bz receptor subtypes as targets for selective drugs. Curr Med Chem (2007) 1.06
Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers. Hum Psychopharmacol (2008) 1.03
Predictive, interactive multiple memory systems. Hippocampus (2010) 1.02
Rapid and continuous modulation of hippocampal network state during exploration of new places. PLoS One (2013) 1.01
Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem. Eur J Pharmacol (1996) 1.01
Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor gamma2 F77I point mutation. Eur J Neurosci (2005) 1.00
Astrocytes convert network excitation to tonic inhibition of neurons. BMC Biol (2012) 0.99
In the Zzz zone: the effects of Z-drugs on human performance and driving. J Med Toxicol (2013) 0.99
Graded response to GABA by native extrasynaptic GABA receptors. J Neurochem (2006) 0.99
Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognition. Sci Transl Med (2013) 0.98
Forebrain and midbrain distribution of major benzodiazepine-sensitive GABAA receptor subunits in the adult C57 mouse as assessed with in situ hybridization. Neuroscience (2007) 0.98
Adverse reactions to zolpidem: case reports and a review of the literature. Prim Care Companion J Clin Psychiatry (2010) 0.96
Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology. Pharmacol Rev (2011) 0.96
Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care. Prim Care Companion J Clin Psychiatry (2007) 0.96
Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism. Front Neurosci (2014) 0.95
Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder. J Clin Psychopharmacol (2009) 0.93
EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia. J Psychopharmacol (2011) 0.92
Zolpidem and traffic safety - the importance of treatment compliance. Curr Drug Saf (2007) 0.92
Acute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly use. Exp Clin Psychopharmacol (2011) 0.91
Effects of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam. Neuropharmacology (2009) 0.90
Pharmacological advances in the treatment of insomnia. Curr Pharm Des (2011) 0.90
The impact of tonic GABAA receptor-mediated inhibition on neuronal excitability varies across brain region and cell type. Front Neural Circuits (2014) 0.90
Selective and nonselective benzodiazepine agonists have different effects on motor cortex excitability. Muscle Nerve (2006) 0.90
The amount of astrocytic GABA positively correlates with the degree of tonic inhibition in hippocampal CA1 and cerebellum. Mol Brain (2011) 0.89
Zolpidem arouses patients in vegetative state after brain injury: quantitative evaluation and indications. Am J Med Sci (2014) 0.89
Pharmacological modulation of GABA(A) receptor-mediated postsynaptic potentials in the CA1 region of the rat hippocampus. Br J Pharmacol (1998) 0.88
Sleep EEG changes after zolpidem in mice. Neuroreport (2004) 0.88
Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. J Clin Psychopharmacol (1993) 0.88
Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use. Sleep (2014) 0.88
Constructive memory: past and future. Dialogues Clin Neurosci (2012) 0.88
Differences in the effects of zolpidem and diazepam on recurrent inhibition and long-term potentiation in rat hippocampal slices. Neurosci Lett (1998) 0.88
Benzodiazepine tolerance at GABAergic synapses on hippocampal CA1 pyramidal cells. Synapse (1999) 0.87
Developmental study of benzodiazepine effects on monosynaptic GABAA-mediated IPSPs of rat hippocampal neurons. J Neurophysiol (1993) 0.86
Effects of eszopiclone and zolpidem on sleep-wake behavior, anxiety-like behavior and contextual memory in rats. Behav Brain Res (2010) 0.85
Pharmacological profile of benzodiazepine site ligands with recombinant GABAA receptor subtypes. Eur Neuropsychopharmacol (1996) 0.85
Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers. Curr Med Res Opin (2008) 0.85
Zolpidem arousing effect in persistent vegetative state patients: autonomic, EEG and behavioral assessment. Curr Pharm Des (2014) 0.84
Effect of zolpidem in chronic disorders of consciousness: a prospective open-label study. Funct Neurol (2014) 0.84
Sleep-stabilizing effects of E-6199, compared to zopiclone, zolpidem and THIP in mice. Sleep (2008) 0.84
5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor. Neuropharmacology (2008) 0.84
The role of the hippocampus and 5-HT/GABA interaction in the central effects of benzodiazepine receptor ligands. J Neural Transm (Vienna) (1999) 0.83
alpha5 Subunit-containing GABA(A) receptors mediate a slowly decaying inhibitory synaptic current in CA1 pyramidal neurons following Schaffer collateral activation. Neuropharmacology (2009) 0.83
Residual effects of hypnotic drugs in aging drivers submitted to simulated accident scenarios: an exploratory study. Psychopharmacology (Berl) (2009) 0.83
Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia. Sleep (2000) 0.83
Effects of zolpidem on sedation, anxiety, and memory in the plus-maze discriminative avoidance task. Psychopharmacology (Berl) (2012) 0.82